Introduction
Epileptic seizures are frequent in chromosomal disorders but only occasionally represent as an explicit symptom. A few of these disorders, however, are associated with specific seizure and EEG patterns. [1] [2] [3] Thus, it is assumed that causative chromosomal aberrations offer the opportunity to identify genes which may be involved in idiopathic epilepsies. 2 Juvenile myoclonic epilepsy (JME) accounts for 4-11% of all idiopathic epilepsies. 4 Its main features are myoclonic morning jerks, generalised seizures, absences, polyspike-wave patterns in EEG and often photosensitivity. In the majority of cases age of onset is between 12 and 18 years. In JME-patients several autosomal genes have been reported to show heterozygous (CACNB4, CLCN2, GABRA1, EFHC1) [5] [6] [7] [8] and in a single case homozygous mutations (GABRD). 9 Further loci have been linked to chromosomes 5q, 6p and 15q. [10] [11] [12] However, most forms of JME seem to follow poly-or oligogenic inheritance. The microdeletion 22q11.2 (incidence 1:4000) is associated with cardiac defects, palatal anomalies, mental retardation, dysmorphic features and sometimes psychosis. The resulting phenotype is variably referred to as Velocardiofacial syndrome or DiGeorge syndrome (OMIM 188400). About 20% of the patients suffer from epileptic seizures. 13 Unfortunately, in most reports on this syndrome the epilepsy phenotype is not further specified or simply described as being symptomatic. Independently, hypocalcemia, fever and recurrent infections being frequent symptoms of this syndrome are seizure-provoking factors as well. However, despite considering such precipitating events, Kao et al. 14 reported a significantly increased prevalence of unprovoked seizures in individuals with del(22)(q11.2) and suggested generalised epilepsy being a primary manifestation of the disorder. So far, only a few studies focused on the potential connection between certain epilepsy phenotypes and this microdeletion locus. Coppola et al. 15 described two patients with a del(22)(q11.2) and an epilepsy resembling Rolandic epilepsy. Both patients had sporadic Rolandic or occipital partial-onset seizures with clinical and electroencephalographic features of benign idiopathic childhood epilepsy. In addition, familial partial epilepsy with variable foci has been linked to 22q11-q12. 16 Family members had mostly nocturnal seizures arising from frontal, temporal, and occasionally occipital foci. However, a second report could narrow down the region to 22q12. 17 Thus, the putative candidate gene for this epilepsy disorder is not expected to be within, but distal to the common microdeletion locus 22q11.2. Furthermore, there were single reports on patients carrying the deletion and presenting with atypical absences 18 or generalised seizures 19 , respectively.
Baralle et al. 20 reported on a mother and her son which both had a microdeletion 22q11.2. The mother presented with a tremor-like We report on an adolescent female with Velocardiofacial syndrome (del (22)(q11.2)) and an epilepsy phenotype resembling juvenile myoclonic epilepsy (JME). Clinically, the patient has characteristic signs of both disorders. JME has been linked to several chromosomes, but has not been related to 22q11.2 and is rarely observed in other genetic syndromes. We discuss possible explanations for a relationship between the chromosomal aberration and epilepsy as well as the importance of precise delineation of both epilepsy phenotypes and genetic defects in chromosomal disorders. ß 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
myoclonic movement disorder affecting head, trunk and limbs since infancy. However, epileptic seizures were not reported in this family.
Here we report on a patient with both JME and a microdeletion 22q11.2 and discuss possible explanations for a relationship between the two disorders and highlight the importance of a precise delineation of both genetic defect and epilepsy phenotype.
Case report
Our female patient is the first child of consanguineous parents (second degree cousins). Family history further revealed a paternal female cousin with epilepsy, a paternal cousin with trisomy 21 and several paternal family members that developed dementia at old age. The mother developed an abdominal teratoma after birth of the patient's healthy younger brother.
The patient was born by forceps at week 38 with intrauterine growth retardation (2140 g, 47 cm). She suffered from a minor ventricular septum defect. Psychomotor and speech delay were reported as well as behavioural problems.
Myoclonic jerks symmetrically involving the arms without disturbance of consciousness appeared for the first time at the age of 14 years and from then occurred nearly daily in the morning hours. First generalised tonic-clonic morning seizures without aura occurred at the same age.
Psychiatric problems became obvious one day after the second generalised seizure. The girl was agitated and confused. She suffered from sleep disturbances and acoustic hallucinations.
Antiepileptic pharmacotherapy proved to be difficult. While valproate completely suppressed tonic-clonic seizures and diminished myoclonic jerks, it led to significant gain of weight. Phenobarbital did not completely suppress seizures, whereas lamotrigine worsened myoclonic jerks. Furthermore, the combination of antiepileptic and psychopharmacologic medication caused side effects: low dose amisulpride caused parkinsonism, clozapine severely enhanced myoclonic jerks, olanzapine seemed to enhance psychiatric symptoms. Psychopharmocological treatment could only modulate but never abolish psychiatric symptoms.
At the age of 18 years the patient's height was 158 cm (P25), the weight was 53 kg (P25-50). The patient had a long narrow face with prominent chin, high nasal bridge, broad nasal root and low set ears. Physical examination revealed rhinolalia aperta, asymmetric and high palate, short velum palatinum, deviation of the nasal septum and open mouth with dental crowding. Fingers were long and slender. Neurological examination was unremarkable. There was no evidence for recurrent infections in childhood. Serum calcium levels were normal (2.35 mmol/l). Neuropsychological assessment revealed impairment of speech functions and an IQ of 72. MRI of the brain was normal. EEG revealed bilateral synchronous fronto-central (poly) spike-wave discharges with photosensitivity similar to EEG features in JME (Fig. 1) .
Psychiatric examination revealed adequate orientation with incoherent and intricate thinking, acoustic hallucinations and apparent parathymia.
Based on the above mentioned features and psychiatric symptoms we suspected a microdeletion 22q11.2, which was confirmed by FISH with probes from the critical DiGeorge region (Vysis R) [46,XX,del(22)(q11.2)(D22S553-,D22S609-,D22S942-)]. To narrow down the breakpoints, MLPA (Multiplex Ligationdependent Probe Amplification) was performed and revealed a deletion of about 2.5 Mb (spanning the most commonly deleted region and presumably containing 30 genes between CDC45L to LZTR1).
Discussion
The epilepsy phenotype of our patient with the diurnal pattern of myoclonias, generalised tonic-clonic seizures and pathologic EEG with photosensitivity and generalised spike waves is characteristic for JME. The age of onset and good response to valproate further support this diagnosis, but molecular genetic testing of the 5 known JME genes has not been performed. Other features as cardiac defect, dysmorphic features and psychiatric findings pointed to microdeletion 22q syndrome which was verified by FISH and MLPA.
Although the syndrome's phenotype is well known to include epileptic seizures and epilepsy causing genes are predicted within the 22q region 14, 17 the epilepsy phenotypes of patients carrying the deletion are often described sparsely, a fact that hampers a reliable evaluation of JME or JME-like epilepsy as perhaps being characteristic for a del(22)(q11.2). The rare descriptions of epilepsy phenotypes in this syndrome include Rolandic epilepsy 15 , atypical absences 18 and generalised seizures 14, 19 , whereas JME has so far not been reported in this context. However, already Baralle et al. 20 suggested myoclonic movement disorders to be part of the microdeletion syndrome 22q11.2, but in that study no EEG findings were mentioned, thus the nature of the myoclonias remains uncertain. No JME candidate gene is currently suspected on 22q11.2. 21, 22 No ion channel genes have been reported within the common deleted region.
It cannot be excluded that the co-occurrence of JME and microdeletion 22q11.2 in our patient might simply be coincidental. Both syndromes are known to be frequent genetic disorders. The occurrence of epilepsy (not further specified) in a patient's cousin as well as parental consanguinity would also support that interpretation. Because of normal serum calcium, syndrome-associated facultative hypocalcemia seems not to be responsible for epileptogenesis in this case. In our case a syndrome-associated demasking of a latent predisposition to seizures/JME due to hemizygosity of the microdeleted area could be assumed as well. A developing hyperthyroidism can exacerbate seizures in JME. 23 Some similar processes might be triggered by the chromosomal imbalance in our patient, although we could not yet identify a putative responsible gene. Moreover, in most patients with both Velocardiofacial syndrome and seizures the microdeletion was confirmed by FISH. Thus, a potential correlation of the microdeletion's size and their epilepsy phenotype remains unclear.
The precise delineation of the extent of a deletion by other routine cytogenetic methods, such as MLPA rather than FISH, might be a way to reliably correlate single epilepsy syndromes with the deletion of certain genes and to identify novel epilepsy genes. Furthermore, our case illustrates the importance of a precise description of epilepsy phenotypes in chromosomal and other genetic disorders in order to enable the identification of putative candidate genes causing idiopathic epilepsy by genotype-phenotype correlation.
